chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was considered medically important (OMIC). Information regarding Prevnar was received from a healthcare professional regarding a patient who experienced pneumonia and drug ineffective. The patient received the vaccine. Relevant medical history was not provided. Indication for Prevnar was immunization. Product was administered on an unspecified date. Dose regimen was not provided. Concomitant medications were not reported. The patient developed pneumonia on an unspecified date. The reporter stated that 16 patients in 19 days had been diagnosed with pneumonia from his clinic. All were under 2 years of age, and it was not known if each child had received doses of Prevnar. The reporter indicated that 16 children experienced this event; however, they are not presently identifiable. Additional reports will be generated when identifying information is provided. No additional information was available at the time of this report.
Moderna vaccine was administered to patient who is not 18 years of age.  Incident recognized as patient returned to clinic for second moderna vaccine. Patient under the age and vaccination not recommended therefore second dose of Moderna vaccine was withheld
Localized inflamation and rash. Start CLARITIN next 1-2 weeks. Hydrocortisone crm BID.
High fever; Extreme body ache; I still have chills and feel sick; I still have chills and feel sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "High fever"; PAIN (non-serious), outcome "unknown", described as "Extreme body ache"; CHILLS (non-serious), ILLNESS (non-serious), outcome "not recovered" and all described as "I still have chills and feel sick".  The lot number for bnt162b2 was not provided and will be requested during follow up.
An employee was administering a dose of the Moderna Covid-19 vaccine & the syringe came apart & vaccine splashed in employee's eye.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT (An employee was administering a dose of the Moderna Covid-19 vaccine & the syringe came apart & vaccine splashed in employee's eye.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT (An employee was administering a dose of the Moderna Covid-19 vaccine & the syringe came apart & vaccine splashed in employee's eye.). On 08-Nov-2021, ACCIDENTAL EXPOSURE TO PRODUCT (An employee was administering a dose of the Moderna Covid-19 vaccine & the syringe came apart & vaccine splashed in employee's eye.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not provided. Treatment details were not provided.
Four days following my first dose I developed several patches of itchy pustules on my waist and thigh, all on my right side
Thigh swollen, not red, but warm and firm. Pt c/o pain and very fussy and not bearing it. Treated w/Benadryl/Advil/Motrin prn.
Body aches with SERVERE PAIN focused on areas of previous injury (right ankle, lumbar  spine ,  bilat hips, and bilat knees. Hyper tension chest pain and palpitations. BP was hovering around 150 to 190 Systolic and 90 to 100 diastolic with pulse starting at 120 bpm and staying in that range.  around 10:00 at the E.R. it finally started to come down to normal 130/76 pulse 74.
Pt received an expired vaccine by error. Vaccine expired on 11/08/2022.  Pt was contacted to come and repeat the dose.
Devel sore throat & inj site rxn of 4inch area erythema,warmth & tenderness.Resolved p/48 hr. 3 days p/vax pt devel malaise,  fever ("99+"), left arm weakness & arthralgia. Sx resolved p/1 wk. 01/98 pt exp arthralgia & extreme fatigue
This 80 year old woman was admitted with covid pneumonia.  She was treated with remdesivir and steroids and is improved.  She will taper steroids.  There was concern about possible secondary infection and she is completing oral antibiotics for this.   She did have hypoglycemia on admission.  This has resolved.  However would monitor glucose as steroids weaned.   She did have mild elevation of troponin on admission.  This was felt to be type 2 MI.  Echo showed LVEF 56%.  She was seen by cardiology.     She was seen here for a stage III pressure ulcer to left buttock.  Wound care directed by wound care nurse.
about 10 days p/vax pt devel vomiting & intermittent dec mental status;@ less than 2 wks post vax pt dx w/grade II-III Reye synd;no other contributing factors were identified;
Approx. 10 min. post-vaccine Pt began feeling lightheaded and nauseas. Pt transferred to med obs via wc. Pt reported feeling better after lying down and drinking water. Vitals were obtained and monitored. Pt was released at 5:15pm. Vitals as follows: 5:00 - HR 73 BP 103/70 RR 16 Sp02 98% 5:10 - HR 77 BP 106/72 RR 16 Sp02 98% 5:15 - HR 76 BP 105/72 RR 16 Sp02 98%
Developed a gluten allergy. Stomach pains when eating wheat. Had to go to primary and urgent care and eliminate and reintroduce foods to determine what the issue was.
adult dose administered to 22 month old; adult dose administered to 22 month old; This case was reported by a pharmacist via call center representative and described the occurrence of adult product administered to child in a 22-month-old patient who received HAV (Havrix adult) for prophylaxis.   On 5th August 2022, the patient received Havrix adult 1 ml. On 5th August 2022, unknown after receiving Havrix adult, the patient experienced adult product administered to child and accidental overdose. On an unknown date, the outcome of the adult product administered to child and accidental overdose were unknown.     Additional Information: GSK Receipt Date: 5-Aug-2022 Reporter's comment: The health care professional reported that 1ml of havrix adult dose was administered instead of 0.5 ml to a 22 month old child. No other information available. The reporter consented to follow up. Additional supportive information: A 22 month old patient received a dose of Havrix adult dose of 1ml instead of 0.5 ml, which led to accidental overdose and adult product administered to child.
This spontaneous report as received from a physician via company representative refers to an approximately 70 years old patient of unknown gender. On unspecified date in approximately 2012 (reported as "2 years ago") the patient was vaccinated with ZOSTAVAX 1 single shot (route, lot # not reported). On an unknown date the patient experienced a mild case of shingles after receiving ZOSTAVAX. The patient sought medical attention by calling to the doctor's office. The patient recovered from a mild case of shingles on unknown date. Relatedness between the event and ZOSTAVAX was not specified. Additional information has been requested.
redness inside of arm to elbow; swelling; Chills; Fatigue; Vomit; itching inside of arm to elbow; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever), CHILLS (Chills), FATIGUE (Fatigue), VOMITING (Vomit) and ERYTHEMA (redness inside of arm to elbow) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PYREXIA (fever), FATIGUE (Fatigue), VOMITING (Vomit) and PRURITUS (itching inside of arm to elbow). On 24-Feb-2021, the patient experienced CHILLS (Chills). On an unknown date, the patient experienced ERYTHEMA (redness inside of arm to elbow) and SWELLING (swelling). On 25-Feb-2021, PYREXIA (fever) and CHILLS (Chills) had resolved. At the time of the report, FATIGUE (Fatigue), VOMITING (Vomit), ERYTHEMA (redness inside of arm to elbow), SWELLING (swelling) and PRURITUS (itching inside of arm to elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided  No treatment medication was provided
Heart gave a "great big pump" and is happening more frequently; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart gave a "great big pump" and is happening more frequently) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21E and 016B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart gave a "great big pump" and is happening more frequently). At the time of the report, PALPITATIONS (Heart gave a "great big pump" and is happening more frequently) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication reported. No treatment was provided.
The child was in our office for 4 month physical & immunization update.  The child was supposed to receive DTaP #2 but it was documented and sent to health as Tdap #2.
Developed shingles 4 days after 2nd dose; This is a spontaneous report received from a contactable Other HCP via Pfizer sales representative.   A 33-year-old male received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and Expiration date was unspecified) on unspecified date as single dose (at 33  years of age),  for COVID-19 immunisation.  Medical history included shingles; Patient has history of 5 previous cases of shingles. Historical vaccine included first dose of BNT162B2. Concomitant medication was not reported.    The patient developed shingles 4 days after 2nd dose on an unspecified date. The patient did not have treatment.  Outcome of event shingles was unknown.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Patient broke out in hives & lips swoll up. Hives continued to appear for 10 days after vaccination. Pt took BENADRYL. Vaccination area formed hard spot as well. Pt is now healed.
shortly after patient got the vaccine , patient felt dizzy and passed out , patient was awake until EMT TAKE OVER
Red rash on injection site, warm to touch, painful, started to appear 10days later, doctor told me to take benadryl and use ice pack. It lasted about a week.
Pt showed vasovagal syncope episode. I had her lay down on the floor with fully covered blanket and provided water little by little when she was able to upright position. She was alert all the time and didn't hit any place since I was catching her when laying her down.
This spontaneous report was received from a registered nurse concerning a female patient on an unknown age with latex sensitivity. The patient's medical history, historical drugs and concomitant therapies were not reported. On 17-FEB-2017, the patient was vaccinated with VARIVAX "in the upper arm" (dose, route, lot number and expiration date were not reported) for varicella vaccination. On 17-FEB-2017 in the evening (reported as by the evening of the same day), the patient experienced edema, heat, redness, tenderness and soreness that extended about 50 millimeters from the injection site. All the events were described as being cellulitis (injection site cellulitis) by the nurse. The patient was treated with unspecified "comfort measures and elevation of the arm". On 20-FEB-2017, the  symptoms improved greatly and actually they were almost fully recovered, but not completely healed. No laboratory diagnostics were performed.  The causal relationship between the event and VARIVAX was not reported. Additional information has been requested.
Mild side effects after receiving a booster yesterday; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Mild side effects after receiving a booster yesterday) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Mild side effects after receiving a booster yesterday). At the time of the report, VACCINATION COMPLICATION (Mild side effects after receiving a booster yesterday) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.  The patient asked if it was okay to take Tylenol.   Reporter did not allow further contact
2nd Moderna vaccine was given 13 days too early. Patient did not experience any adverse reactions, but will follow up to make sure.
Rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
He contracted COVID-19 on 05/17/2022 6 days after he tested positive for Flu A and flu B with symptoms of fever, congestion, sore throat, cough, chest tightness, headache and fatigue. He was not prescribed any medication upon his visit to the Urgent Care. The fever broke after 4 days, but chest tightness and congesting were beginning to abate. His symptoms were almost fully resolved after day 6. He is fully recovered with no lingering symptoms.
This child had erythema 8 x 10 am at the injection site with induration, 48 hours after injection.
Left arm numbness & tingling after immunizations still persist seen by ped md and neurology.
HEART ATTACKS; This spontaneous report received from a consumer via a company representative via social media concerned 5 decade old multiple (3) male patients of an unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patients previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1), (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, start therapy date were not reported 1 total administered for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination (Dose number in series 1). The patients additionally received covid-19 vaccine ad26.cov2.s (Dose number in series 2), (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. Age at time of vaccination 5 decade old. No concomitant medications were reported.  On an unspecified date, the patients died from heart attacks (Dose number in series 2). It was unspecified if an autopsy was performed. It was reported as "3 male friends in their 40s in a 3 week span got the booster and died days afterword from heart attacks. Coincidence". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20221253631-Heart attacks. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.; Reported Cause(s) of Death: HEART ATTACK
At my yearly Dermatologist appointment, doctor found a mass near my thigh. Doctor performed a Punch Biopsy and found that is was Melanoma. Had the mass removed. I go to a Dermatologist every 3 months for a check-up.
2 arms redness and purple dots; 2 arms redness and purple dots; This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER8737 and expiration date was not reported), via an unspecified route of administration in right arm, on 23Apr2021 at 14:00 (at the age of 46-years-old), as first dose, single for COVID-19 immunization. Medical history included depression. It was unknown if the patient had any allergies. Concomitant medications included buspirone hydrochloride (BUSPAR) and celecoxib (CELEXA). Prior to vaccination, the patient did not receive any other vaccine within 4 weeks prior and was not diagnosed with COVID-19. The patient experienced redness in the 2 arms and purple dots on 23Apr2021 at 20:00. The events were reported as non-serious and resulted in the doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received by the patient for these events. The outcome of these events was not recovered at the time of report.  No follow up attempts are needed. No further information is expected.
In clinic reporting pain, itching, redness and increased warmth to upper right arm - localized to vaccine site, that began the same evening the vaccine was administered. Patient & parent report gradual increase in these symptoms over past two days, with development of rash to site only. No fever nor difficulty breathing; no seizure activity.
could not move the extremity; swelling from the arm; bruising from the injection site down to her elbow; headache; This spontaneous report has been received from a registered nurse via an employee referring to a 70 years old female patient. The patient did not have any concomitant medication or drug reactions/allergies. Pertinent medical history included autoimmune deficiency.   On 14-JUN-2019 (at 09:00 am), the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # R031812, expiration date 26-SEP-2020; dose was unknown) subcutaneously in the right arm to prevent pneumonia.         On 14-JUN-2019 (by 16:00 pm), the patient called the doctor's office to report that she experienced a headache, swelling from the arm and could not move the extremity. The patient also reported bruising from the injection site down to her elbow. The patient did not sink medical attention. No treatment was given for the events. No lab diagnostics/studies were performed. The patient recovered from all the events on 16-JUN-2019 (reported as within 2 days). The causality between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was unknown. No product quality complaint (PQC) presented.
That vaccine gave me the shingles/ Suspected vaccination failure; gave me the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 13-AUG-2022.  Reporter's Comments: This case was reported by patient via interactive digital media. The vaccine gave shingles to the patient. Additional Supportive Information: This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation for herpes zoster were unknown. The follow up would not be possible as contact details were not provided.
doses given after temperature excursion; doses given after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (doses given after temperature excursion) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 28-Nov-2021, the patient experienced PRODUCT STORAGE ERROR (doses given after temperature excursion). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion). On 28-Nov-2021, PRODUCT STORAGE ERROR (doses given after temperature excursion) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Resident got vaccine in January of 2021. Resident began having shortness of breath and feeling bad. Tested on 7/26/2021 and was positive for COVID. resident sent to ER due to low O2 sats and has since been hospitalized with no plans for discharge.
0n 3/25/10 Patient had immuns at approx. 0930 with lyncosce. Had sx lasting approximately 11/2 min prior to 12:46pm. Witnessed by mother. Had + LOL, suffering and arching, eyes rolled up, apneic with perioral cyanosis. EMS called and taken to ER. SAT labs, CXR, CT, EEG WNL. Admitted; 3/26/10. Dx Prob. Viral Syndrome with ass. febrile sx masked by Tylenol.
headache, 101 degree fever, chills, sweats started at 4 am and ended at 9 am with continued rest and Tylenol. Was able to go to  work at 11:15 am  on 2/3/2021
Apparently my lymph nodes in the arm of injection (left side) became swollen presumably from the vaccinations.  They remained swollen at routine mammogram first conducted  April 30, 2021, almost two months after second vaccination.
Took the flu shot on Sept 30 2018 and developed either Bell palsy or GBS.